No Detail Found!

Effect of Goal-directed Fluid Therapy on the Shedding of the Glycocalyx Layer in Retroperitoneal Tumour Resection

Author(s)
Xiaoyu Wang Department of Anaesthesiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University,Beijing,China
Yi Duan Department of Anaesthesiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University,Beijing,China
Zhifeng Gao Department of Anaesthesiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University,Beijing,China
Jie Gu Department of Anaesthesiology, Peking University International Hospital,Beijing,China
Abstract
Objective: To evaluate the effects of different stroke volume variation (SVV) targets on endothelial glycocalyx (EG) shedding. Study Design: Randomised controlled trial. Place and Duration of Study: Department of Anaesthesiology, Peking University International Hospital, Beijing, China, from February to June 2018. Methodology: Patients undergoing elective retroperitoneal tumour resection were assigned to one of two groups. SVV 9% group (n=40), who received a more traditional (liberal) uid therapy with SVVd 9%; and the SVV 14% group (n=40), received restrictive uid therapy with SVV d 14%. Patients serum concentrations of syndecan-1 (SDC-1), interleukin-6 (IL-6) and tumour necrosis factor-± (TNF-±) were measured at the time that patients entered the operating theatre; at 1- and 4-hours following initiation of the surgery; and at 24- and 72-hours post-surgery. Postoperative complications, and one-year survival rates were also noted. Results: Perioperative serum SDC-1, IL-6 and TNF-± concentrations were significantly elevated in both groups, which were more pronounced in SVV 9% (p = 0.028, <0.001, and <0.001 respectively). A positive correlation was observed between SDC-1 and TNF-±, L-6, and infusion volume, respectively. Postoperative complications, including fever and blood transfusion, were more aggravated in SVV 9% than those in SVV 14% (80% vs. 59%, and 45% vs. 23.1%, both p <0.05). However, no significant difference in the one-year survival rate was observed. Conclusion: Using SVV 14% as a target for guiding uid therapy in elective retroperitoneal tumour resection was associated with reduced perioperative glycocalyx shedding, ameliorated inflammatory response, and reduced postoperative complications.
Publication Details
Page(s) 1179-1185
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 10, Year: 2021

Request the full text from PASTIC

Keywords
fluid therapy, Stroke volume, Interleukin-6, Randomised controlled trial, Tumour necrosis factor-alpha, glycocalyx, Retroperitoneal neoplasms
0

Citations

0

Downloads

49

Views